<!doctype html>
<!--
  Minimal Mistakes Jekyll Theme 4.27.1 by Michael Rose
  Copyright 2013-2025 Michael Rose - mademistakes.com | @mmistakes
  Free for personal and commercial use under the MIT license
  https://github.com/mmistakes/minimal-mistakes/blob/master/LICENSE
-->

<html lang="en" class="no-js">
  <head>
    <meta charset="utf-8">

<!-- begin _includes/seo.html --><title>BioPharma AI Weekly - Issue #2 (2025.01.17)</title>
<meta name="description" content="AI, BioPharma, Drug Discovery 분야의 최신 소식을 전합니다.">


  <meta name="author" content="You Young Song">
  
  <meta property="article:author" content="You Young Song">
  


<meta property="og:type" content="article">
<meta property="og:locale" content="en_US">
<meta property="og:site_name" content="BioPharma AI Weekly">
<meta property="og:title" content="BioPharma AI Weekly - Issue #2 (2025.01.17)">
<meta property="og:url" content="http://localhost:4000/old/2025-01-17-BioPharma-AI-Weekly.html">


  <meta property="og:description" content="AI, BioPharma, Drug Discovery 분야의 최신 소식을 전합니다.">







  <meta property="article:published_time" content="2025-01-17T00:00:00+09:00">






<link rel="canonical" href="http://localhost:4000/old/2025-01-17-BioPharma-AI-Weekly.html">












<!-- end _includes/seo.html -->



  <link href="/feed.xml" type="application/atom+xml" rel="alternate" title="BioPharma AI Weekly Feed">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<script>
  document.documentElement.className = document.documentElement.className.replace(/\bno-js\b/g, '') + ' js ';
  
</script>

<!-- For all browsers -->
<link rel="stylesheet" href="/assets/css/main.css">
<link rel="preload" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@latest/css/all.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'">
<noscript><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@latest/css/all.min.css"></noscript>



    <!-- start custom head snippets -->

<!-- insert favicons. use https://realfavicongenerator.net/ -->

<!-- end custom head snippets -->

  </head>

  <body class="layout--default" dir="ltr">
    <nav class="skip-links">
  <ul>
    <li><a href="#site-nav" class="screen-reader-shortcut">Skip to primary navigation</a></li>
    <li><a href="#main" class="screen-reader-shortcut">Skip to content</a></li>
    <li><a href="#footer" class="screen-reader-shortcut">Skip to footer</a></li>
  </ul>
</nav>

    

<div class="masthead">
  <div class="masthead__inner-wrap">
    <div class="masthead__menu">
      <nav id="site-nav" class="greedy-nav">
        
        <a class="site-title" href="/">
          BioPharma AI Weekly
          
        </a>
        <ul class="visible-links"></ul>
        
        <button class="greedy-nav__toggle hidden" type="button">
          <span class="visually-hidden">Toggle menu</span>
          <div class="navicon"></div>
        </button>
        <ul class="hidden-links hidden"></ul>
      </nav>
    </div>
  </div>
</div>


    <div class="initial-content">
      <h1 id="ai-technology-updates">AI Technology Updates</h1>

<h1 id="ai-in-biopharma">AI in BioPharma</h1>

<h1 id="conferences--events">Conferences &amp; Events</h1>

<h3 id="fda-drafts-guidance-for-ai-in-drug-development">FDA Drafts Guidance for AI in Drug Development</h3>

<ul>
  <li>기사 <a href="https://www.techlifesci.com/i/154395775/fda-drafts-guidance-for-ai-in-drug-development">https://www.techlifesci.com/i/154395775/fda-drafts-guidance-for-ai-in-drug-development</a></li>
  <li>공지 <a href="https://www.fda.gov/news-events/press-announcements/fda-proposes-framework-advance-credibility-ai-models-used-drug-and-biological-product-submissions?utm_source=substack&amp;utm_medium=email">https://www.fda.gov/news-events/press-announcements/fda-proposes-framework-advance-credibility-ai-models-used-drug-and-biological-product-submissions?utm_source=substack&amp;utm_medium=email</a></li>
  <li>전문 <a href="https://www.fda.gov/media/184830/download">https://www.fda.gov/media/184830/download</a></li>
  <li>FDA가 약물 및 생물학적 제제의 안전성, 효과성, 품질에 관한 규제 결정을 지원하기 위한 인공지능(AI) 활용에 관한 초안 지침 발표
    <ul>
      <li>AI는 환자 결과를 예측하고, 질병 진행 예측 변수를 이해하며, 대규모 데이터를 처리 및 분석하는 데 활용될 수 있음</li>
      <li>FDA는 AI 모델의 신뢰성을 확보하고, 특정 용도에서 AI 모델이 신뢰할 만한 결과를 제공할 수 있도록 평가하는 데 중점을 둠</li>
      <li>이 지침은 FDA의 기존 AI 관련 검토 프로세스와 일치하며, 위험 기반 접근법을 제안</li>
    </ul>
  </li>
  <li>The FDA wants feedback on this draft and is welcoming public comments for the next 90 days. It’s a good opportunity for developers, sponsors, and others to weigh in on how AI should be regulated in the drug development space.</li>
</ul>

<h3 id="one-third-of-pharma-molecules-now-come-from-china">One-Third of Pharma Molecules Now Come from China</h3>

<ul>
  <li>기사 <a href="https://www.techlifesci.com/i/154395775/one-third-of-pharma-molecules-now-come-from-china">https://www.techlifesci.com/i/154395775/one-third-of-pharma-molecules-now-come-from-china</a></li>
  <li>출처 <a href="https://www.linkedin.com/posts/eric-dai-bioe_an-astounding-figure-from-a-recent-stifel-activity-7282572161335050240-tlc6?utm_source=share&amp;utm_medium=member_desktop">https://www.linkedin.com/posts/eric-dai-bioe_an-astounding-figure-from-a-recent-stifel-activity-7282572161335050240-tlc6?utm_source=share&amp;utm_medium=member_desktop</a></li>
  <li>중국 바이오텍의 부상: 주요 제약사가 인수하는 분자의 약 1/3이 현재 중국에서 유래하며, 이는 4년 전 거의 없었던 상황에서 급격히 변화</li>
  <li>산업 표준화의 영향: 초기 약물 개발의 표준화된 워크플로와 기술로 인해 지리적 요소의 경쟁 우위가 줄어듦</li>
  <li>미국 바이오텍의 경쟁력 우려: 미국의 바이오텍 투자 대비 수익률(ROI)에 의문이 제기되며, 점점 더 많은 분자가 중국 등 외부에서 조달됨</li>
  <li>제조업 아웃소싱에 비유: 에릭 다이는 20세기 후반 제조업이 비용 효율성과 역량 때문에 해외로 이동했던 것처럼, 약물 개발도 유사한 경로를 따를 가능성이 있다고 분석</li>
  <li>미국 모델의 한계: 미국의 높은 벤처 자금 조달이 항상 매력적인 인수 자산으로 이어지지 않는다는 점에서 문제 제기</li>
</ul>

<h3 id="insilico-medicine-httpswwwbiopharmatrendcompost1103-insilico-medicine-licenses-second-ai-generated-cancer-drug-candidate-in-a-550m-dealutm_sourcesubstackutm_mediumemail">Insilico Medicine <a href="https://www.biopharmatrend.com/post/1103-insilico-medicine-licenses-second-ai-generated-cancer-drug-candidate-in-a-550m-deal/?utm_source=substack&amp;utm_medium=email">https://www.biopharmatrend.com/post/1103-insilico-medicine-licenses-second-ai-generated-cancer-drug-candidate-in-a-550m-deal/?utm_source=substack&amp;utm_medium=email</a></h3>

<ul>
  <li>AI 플랫폼으로 개발된 두 번째 항암제를 Menarini Group에 라이선스하며 종양학 분야를 강화함. ($2K 초기 지급, up to $550M)</li>
  <li>동시에 장에 국한된 PHD1/2 억제제를 발표해 염증성 장질환 치료에 대한 AI 기반 신약 개발 역량을 부각함.</li>
</ul>

<h3 id="novo-nordisk-httpswwwbiopharmatrendcompost1096-novo-nordisk-and-valo-health-expand-ai-collaboration-for-cardiometabolic-drug-discoveryutm_sourcesubstackutm_mediumemail">Novo Nordisk <a href="https://www.biopharmatrend.com/post/1096-novo-nordisk-and-valo-health-expand-ai-collaboration-for-cardiometabolic-drug-discovery/?utm_source=substack&amp;utm_medium=email">https://www.biopharmatrend.com/post/1096-novo-nordisk-and-valo-health-expand-ai-collaboration-for-cardiometabolic-drug-discovery/?utm_source=substack&amp;utm_medium=email</a></h3>

<ul>
  <li>Valo Health와 최대 20개 심혈관·대사질환 치료제를 공동 개발하기 위해 약 190백만 달러 선지급, 최대 46억 달러 마일스톤 계약 체결.</li>
  <li>비만, 제2형 당뇨, 심혈관질환 등 대사질환 분야에서 Valo의 Opal 플랫폼을 활용해 예측적 신약개발을 가속화함.</li>
</ul>

<h3 id="merck-kgaa-httpswwwbiopharmatrendcompost1099-merck-kgaa-adopts-quris-ais-organ-on-chip-platform-for-preclinical-drug-safety-testingutm_sourcesubstackutm_mediumemail">Merck KGaA <a href="https://www.biopharmatrend.com/post/1099-merck-kgaa-adopts-quris-ais-organ-on-chip-platform-for-preclinical-drug-safety-testing/?utm_source=substack&amp;utm_medium=email">https://www.biopharmatrend.com/post/1099-merck-kgaa-adopts-quris-ais-organ-on-chip-platform-for-preclinical-drug-safety-testing/?utm_source=substack&amp;utm_medium=email</a></h3>

<ul>
  <li>Quris-AI의 organ-on-chip Bio-AI 플랫폼으로 간·신장 독성 예측을 AI 기반으로 수행해, 동물실험 의존도 감소 기대.</li>
  <li>비임상 안전성 시험 효율을 높여 신약개발 비용과 시간을 절감할 수 있을 것으로 전망.</li>
</ul>

<h3 id="reinvent-webapp-project-httpswwwlinkedincompostshassan-abdelwahab-5b2493193_welcome-activity-7284698834205634560x36utm_sourceshareutm_mediummember_desktop">REINVENT WebApp Project <a href="https://www.linkedin.com/posts/hassan-abdelwahab-5b2493193_welcome-activity-7284698834205634560--X36?utm_source=share&amp;utm_medium=member_desktop">https://www.linkedin.com/posts/hassan-abdelwahab-5b2493193_welcome-activity-7284698834205634560–X36?utm_source=share&amp;utm_medium=member_desktop</a></h3>

<ul>
  <li><a href="https://www.linkedin.com/company/163897/">Freie Universität Berlin</a> 석사 과정 학생이 Streamlit으로 REINVENT WebApp 구현해 공개</li>
  <li><a href="https://reinvent-ui.streamlit.app/">https://reinvent-ui.streamlit.app/</a> (현재 beta version) 추후 github repo 공개 예정</li>
</ul>

<h3 id="webinar---iktos-generative-ai-transforming-knowledge-and-drug-design">[Webinar - Iktos] Generative AI: Transforming Knowledge and Drug Design</h3>

<ul>
  <li>1월 22일 수요일 11:00 PM <a href="https://webinars.elsevier.com/elsevier/Gen-AI-Webinar?bmid=ae8c545a288d&amp;bmid_type=member&amp;bmid=ae8c545a288d">https://webinars.elsevier.com/elsevier/Gen-AI-Webinar?bmid=ae8c545a288d&amp;bmid_type=member&amp;bmid=ae8c545a288d</a></li>
  <li><a href="https://standigm.sharepoint.com/:fl:/g/contentstorage/CSP_f7398f5a-0bd5-49d3-b665-6192e273dbc3/EdruoQUL5OlIoIbk0PxFw2YB-V-kS09KV7JVt1-ISrvbmA?e=dxj80n&amp;nav=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">2025 학회, 심포지엄, 웨비나.loop</a></li>
</ul>

<h3 id="demo-insilico-medicine-dora">[Demo] Insilico Medicine DORA</h3>

<ul>
  <li>Science42: DORA (Draft Outline Research Assistant) is an advanced AI-driven tool designed to streamline the process of drafting academic papers and other related documents.</li>
  <li>FREE for 7 days, up to 3 documents <a href="https://pharma.ai/dora">https://pharma.ai/dora</a></li>
  <li>아래는 DORA launch 초기 사용 후기 (24년 7월; 이때는 문서 1개 생성 무료, 월$17 -&gt; 왜 가격이 올랐을까요?)
    <ul>
      <li>Insilico Med에서 Science42 서비스를 오픈했습니다. 과학분야 논문/특허/글 작성을 돕는 이 RAG-LLM기반 서비스이고, 현재 누구나 1 document 작성을 해볼 수 있게 오픈 되어있습니다. 간단하게 정리하고 사용해봤습니다.
        <ul>
          <li>Science42: DORA (Draft Outline Research Assistant) is an advanced AI-driven tool designed to streamline the process of drafting academic papers and other related documents.</li>
          <li>DORA 내용 간단 정리: <a href="https://standigm.sharepoint.com/:p:/s/Multi-ParameterSARTF/EQ9ExLzUKiZMoX385ImHH14B8YUOk4OT6Pz4U-ZgQ3uVzg?e=MJdDN9&amp;xsdata=MDV8MDJ8fGVjOGQwY2M2ZjNlYzRhZmM4YmEwMDhkY2IxMmQ2NDU5fGQ2ODI2YzJhM2E3MTRmYWViOWQzOGY4ZWYyZThhYjJifDB8MHw2Mzg1ODAwNTU2OTUwMDI1Mjh8VW5rbm93bnxWR1ZoYlhOVFpXTjFjbWwwZVZObGNuWnBZMlY4ZXlKV0lqb2lNQzR3TGpBd01EQWlMQ0pRSWpvaVYybHVNeklpTENKQlRpSTZJazkwYUdWeUlpd2lWMVFpT2pFeGZRPT18MXxMMk5vWVhSekx6RTVPalpqWmpkaU5qazNZalprTWpSbU56WTVPR0psT0dFMU5qaGxNMlpoTkRBeFFIUm9jbVZoWkM1Mk1pOXRaWE56WVdkbGN5OHhOekl5TkRBNE56WTROREV5fDAzMDJiOTNiM2NmNDQ1NDY4YmEwMDhkY2IxMmQ2NDU5fGNhMzA2YTBmZmUzZDQ3MmI5YWM5OTk0MTNiMGI5M2I4&amp;sdata=dnhwc1Z5cmNTblFOYXljWFNsNGdNZUkxVUtZeWlIZVBGNm9RWkRYWmRVST0%3D&amp;ovuser=d6826c2a-3a71-4fae-b9d3-8f8ef2e8ab2b%2Cyouyoung.song%40standigm.com">DORA_Insilico-Medicine_</a><a href="https://standigm.sharepoint.com/:p:/s/Multi-ParameterSARTF/EQ9ExLzUKiZMoX385ImHH14B8YUOk4OT6Pz4U-ZgQ3uVzg?e=MJdDN9&amp;xsdata=MDV8MDJ8fGVjOGQwY2M2ZjNlYzRhZmM4YmEwMDhkY2IxMmQ2NDU5fGQ2ODI2YzJhM2E3MTRmYWViOWQzOGY4ZWYyZThhYjJifDB8MHw2Mzg1ODAwNTU2OTUwMDI1Mjh8VW5rbm93bnxWR1ZoYlhOVFpXTjFjbWwwZVZObGNuWnBZMlY4ZXlKV0lqb2lNQzR3TGpBd01EQWlMQ0pRSWpvaVYybHVNeklpTENKQlRpSTZJazkwYUdWeUlpd2lWMVFpT2pFeGZRPT18MXxMMk5vWVhSekx6RTVPalpqWmpkaU5qazNZalprTWpSbU56WTVPR0psT0dFMU5qaGxNMlpoTkRBeFFIUm9jbVZoWkM1Mk1pOXRaWE56WVdkbGN5OHhOekl5TkRBNE56WTROREV5fDAzMDJiOTNiM2NmNDQ1NDY4YmEwMDhkY2IxMmQ2NDU5fGNhMzA2YTBmZmUzZDQ3MmI5YWM5OTk0MTNiMGI5M2I4&amp;sdata=dnhwc1Z5cmNTblFOYXljWFNsNGdNZUkxVUtZeWlIZVBGNm9RWkRYWmRVST0%3D&amp;ovuser=d6826c2a-3a71-4fae-b9d3-8f8ef2e8ab2b%2Cyouyoung.song%40standigm.com">송유영</a><a href="https://standigm.sharepoint.com/:p:/s/Multi-ParameterSARTF/EQ9ExLzUKiZMoX385ImHH14B8YUOk4OT6Pz4U-ZgQ3uVzg?e=MJdDN9&amp;xsdata=MDV8MDJ8fGVjOGQwY2M2ZjNlYzRhZmM4YmEwMDhkY2IxMmQ2NDU5fGQ2ODI2YzJhM2E3MTRmYWViOWQzOGY4ZWYyZThhYjJifDB8MHw2Mzg1ODAwNTU2OTUwMDI1Mjh8VW5rbm93bnxWR1ZoYlhOVFpXTjFjbWwwZVZObGNuWnBZMlY4ZXlKV0lqb2lNQzR3TGpBd01EQWlMQ0pRSWpvaVYybHVNeklpTENKQlRpSTZJazkwYUdWeUlpd2lWMVFpT2pFeGZRPT18MXxMMk5vWVhSekx6RTVPalpqWmpkaU5qazNZalprTWpSbU56WTVPR0psT0dFMU5qaGxNMlpoTkRBeFFIUm9jbVZoWkM1Mk1pOXRaWE56WVdkbGN5OHhOekl5TkRBNE56WTROREV5fDAzMDJiOTNiM2NmNDQ1NDY4YmEwMDhkY2IxMmQ2NDU5fGNhMzA2YTBmZmUzZDQ3MmI5YWM5OTk0MTNiMGI5M2I4&amp;sdata=dnhwc1Z5cmNTblFOYXljWFNsNGdNZUkxVUtZeWlIZVBGNm9RWkRYWmRVST0%3D&amp;ovuser=d6826c2a-3a71-4fae-b9d3-8f8ef2e8ab2b%2Cyouyoung.song%40standigm.com">.pptx</a></li>
          <li>DORA 사용해서 생성해 본 글 : <a href="https://standigm.sharepoint.com/:b:/s/Multi-ParameterSARTF/EUV26lcEG3dFuJu63o3nZC4BxXA9TMOwgU3oCiLuq7PtZA?e=JmUaDo&amp;xsdata=MDV8MDJ8fGVjOGQwY2M2ZjNlYzRhZmM4YmEwMDhkY2IxMmQ2NDU5fGQ2ODI2YzJhM2E3MTRmYWViOWQzOGY4ZWYyZThhYjJifDB8MHw2Mzg1ODAwNTU2OTUwMDI1Mjh8VW5rbm93bnxWR1ZoYlhOVFpXTjFjbWwwZVZObGNuWnBZMlY4ZXlKV0lqb2lNQzR3TGpBd01EQWlMQ0pRSWpvaVYybHVNeklpTENKQlRpSTZJazkwYUdWeUlpd2lWMVFpT2pFeGZRPT18MXxMMk5vWVhSekx6RTVPalpqWmpkaU5qazNZalprTWpSbU56WTVPR0psT0dFMU5qaGxNMlpoTkRBeFFIUm9jbVZoWkM1Mk1pOXRaWE56WVdkbGN5OHhOekl5TkRBNE56WTROREV5fDAzMDJiOTNiM2NmNDQ1NDY4YmEwMDhkY2IxMmQ2NDU5fGNhMzA2YTBmZmUzZDQ3MmI5YWM5OTk0MTNiMGI5M2I4&amp;sdata=S3FYcG9EdTRHY2ZmNHJmd1YzaCszV1c2MCtRZXY0SFFsQ0VqeUNYZ0x3MD0%3D&amp;ovuser=d6826c2a-3a71-4fae-b9d3-8f8ef2e8ab2b%2Cyouyoung.song%40standigm.com">DORA__Revolutionizing Drug Discovery_ AI’s Impact on Small Molecule Development Over 20 Years.pdf</a></li>
          <li>ChatGPT4o 사용해서 생성한 글: <a href="https://standigm.sharepoint.com/:b:/s/Multi-ParameterSARTF/EUZH_qI6kGtKnE8ltP3bCWYBnJWVFUuD_hzLYwc14zRACg?e=wNjtxE&amp;xsdata=MDV8MDJ8fGVjOGQwY2M2ZjNlYzRhZmM4YmEwMDhkY2IxMmQ2NDU5fGQ2ODI2YzJhM2E3MTRmYWViOWQzOGY4ZWYyZThhYjJifDB8MHw2Mzg1ODAwNTU2OTUwMDI1Mjh8VW5rbm93bnxWR1ZoYlhOVFpXTjFjbWwwZVZObGNuWnBZMlY4ZXlKV0lqb2lNQzR3TGpBd01EQWlMQ0pRSWpvaVYybHVNeklpTENKQlRpSTZJazkwYUdWeUlpd2lWMVFpT2pFeGZRPT18MXxMMk5vWVhSekx6RTVPalpqWmpkaU5qazNZalprTWpSbU56WTVPR0psT0dFMU5qaGxNMlpoTkRBeFFIUm9jbVZoWkM1Mk1pOXRaWE56WVdkbGN5OHhOekl5TkRBNE56WTROREV5fDAzMDJiOTNiM2NmNDQ1NDY4YmEwMDhkY2IxMmQ2NDU5fGNhMzA2YTBmZmUzZDQ3MmI5YWM5OTk0MTNiMGI5M2I4&amp;sdata=NFNSckFOWGthcmNKbXFua3ptOUJ6Z2EvNFNkQlNKS2hjM2VmQ3lpNlpyRT0%3D&amp;ovuser=d6826c2a-3a71-4fae-b9d3-8f8ef2e8ab2b%2Cyouyoung.song%40standigm.com">ChatGPT40__The Research Trends in Small Molecule Drug Development Over the Past 20 Years in Light of Advancements in AI Technology.pdf</a></li>
          <li>데모로 글 하나만 생성해 볼 수 있어서 간단하고 일반적인 내용에 대해서 테스트 해봤습니다. 이전에 Insilico GPT가 처음에는 자사 논문 내용 기반 자사 기술 및 연구 내용에 대해 답변해주는 RAG-LLM에서 시작해서, 제가 한달 전쯤에 봤을 때 답변의 근거를 highlight해주는 text evidence 기능이 추가되어 있었습니다. Science42를 준비하면서 중간중간 공개했던 것 같습니다.</li>
          <li>데모로 글 하나만 작성해보고 월 17$의 가치를 가지는지를 판단해보기는 힘들 것 같다는 생각을해서 chatgpt로도 같은 input을 주고 글을 생성시켜봤습니다.</li>
        </ul>
      </li>
    </ul>
  </li>
</ul>

      
    </div>

    

    <div id="footer" class="page__footer">
      <footer>
        <!-- start custom footer snippets -->

<!-- end custom footer snippets -->
        <div class="page__footer-follow">
  <ul class="social-icons">
    

    

    
      <li><a href="/feed.xml"><i class="fas fa-fw fa-rss-square" aria-hidden="true"></i> Feed</a></li>
    
  </ul>
</div>

<div class="page__footer-copyright">&copy; 2025 <a href="http://localhost:4000">BioPharma AI Weekly</a>. Powered by <a href="https://jekyllrb.com" rel="nofollow">Jekyll</a> &amp; <a href="https://mademistakes.com/work/jekyll-themes/minimal-mistakes/" rel="nofollow">Minimal Mistakes</a>.</div>

      </footer>
    </div>

    
  <script src="/assets/js/main.min.js"></script>









  </body>
</html>
